Table 4.
Multivariate analysis of prognostic factors for progression-free survival.
| Variables | HR (95% CI) | P value |
|---|---|---|
| BCLC classs | ||
| C | 1 | |
| B | 0.614 (0.440, 0.856) | 0.004 |
| A | 0.636 (0.449, 0.901) | 0.011 |
| AST (μmol/L) | 1.001 (0.999, 1.002) | 0.324 |
| PLR | 1.001 (1.000, 1.003) | 0.058 |
| NLR | 1.006 (0.986, 1.028) | 0.556 |
| Tumor size | 1.025 (0.992, 1.058) | 0.137 |
| TACE sessions | 0.901 (0.848, 0.958) | 0.001 |
Note. HR: hazard ratio; CI: confidence interval; BCLC: barcelona clinical liver cancer; AST: aspartate aminotransferase; PLR: platelet-to-lymphocyte ratio; NLR: neutrophil-to-lymphocyte ratio; TACE: transcatheter arterial chemoembolization.